You may also like
CytoSorbents Devices Wins Emergency Approval to Treat COVID-19 Patients
The Food and Drug Administration says it granted Emergency Use Authorization for CytoSorbent’s (NASDAQ:CTSO) CytoSorb device to treat patients with confirmed Covid-19 admitted to the ICU with confirmed or imminent respiratory failure.
1 min read
Plasma Expander and Blood Storage Effects on Capillary Perfusion in Transfusion after Hemorrhage
The type of plasma expander used for hemodilution influences the short-term outcome of subsequent volume resuscitation
1 min read
Novel Autologous, High Concentrated Fibrin as Advanced Hemostatic Agent for Coronary Surgery
Autologous bio-regenerative fibrin can be safely prepared, with no time consuming, and was demonstrated to be a useful tool to decrease allogeneic blood transfusion requirements following elective coronary artery bypass grafting surgery. A prospective randomized trial is needed to confirm these findings.
1 min read